INOVIO PHARMACEUTICALS, INC. Net Income (Loss) Attributable to Noncontrolling Interest
INOVIO PHARMACEUTICALS, INC. (INO) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2023-03-01
- INOVIO PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2021-12-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2021-09-30 was $0.00.
- INOVIO PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2021-06-30 was $0.00.
- INOVIO PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2021-03-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2022 was $0.00.
- INOVIO PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2021 was $0.00.
- INOVIO PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2020 was -$1.06M.
- INOVIO PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2019 was -$1.19M.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-01 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | $0.00 derived: sum of 3 quarters · filed 2021-08-09 | $0.00 derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 | $0.00 derived: sum of 2 quarters · filed 2021-05-10 | $0.00 derived: sum of 3 quarters · filed 2021-11-09 | -$469.41K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | -$469.41K derived: sum of 3 quarters · filed 2021-11-09 | -$1.06M 10-K · filed 2023-03-01 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | -$469.41K derived: sum of 2 quarters · filed 2021-11-09 | -$1.06M 10-Q · filed 2021-11-09 | -$1.55M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$469.41K 10-Q · filed 2021-08-09 | -$1.06M 10-Q · filed 2021-08-09 | -$1.55M derived: sum of 3 quarters · filed 2021-08-09 | -$1.99M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | -$594.35K 10-Q · filed 2021-05-10 | -$1.08M derived: sum of 2 quarters · filed 2021-05-10 | -$1.53M derived: sum of 3 quarters · filed 2021-05-10 | -$1.72M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | -$485.34K 10-K · filed 2021-03-01 | -$931.10K derived: sum of 2 quarters · filed 2021-03-01 | -$1.12M derived: sum of 3 quarters · filed 2021-03-01 | -$1.19M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$445.76K 10-K · filed 2021-03-01 | -$637.61K derived: sum of 2 quarters · filed 2021-03-01 | -$707.21K 10-Q · filed 2020-11-09 | -$707.21K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$191.85K 10-K · filed 2021-03-01 | -$261.45K 10-Q · filed 2020-08-10 | -$261.45K derived: sum of 3 quarters · filed 2021-03-01 | -$261.45K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$69.61K 10-K · filed 2021-03-01 | -$69.61K derived: sum of 2 quarters · filed 2021-03-01 | -$69.61K derived: sum of 3 quarters · filed 2021-03-01 | -$69.61K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-03-12 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $0.00 derived: sum of 2 quarters · filed 2018-03-14 | $0.00 derived: sum of 3 quarters · filed 2018-03-14 | $0.00 10-K · filed 2018-03-14 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | $0.00 derived: sum of 4 quarters · filed 2017-03-15 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-08 | $0.00 10-Q · filed 2016-08-08 | $0.00 derived: sum of 3 quarters · filed 2017-03-15 | $0.00 derived: sum of 4 quarters · filed 2017-03-15 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $0.00 derived: sum of 3 quarters · filed 2017-03-15 | $85.86K derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $85.86K derived: sum of 3 quarters · filed 2017-03-15 | $84.77K 10-K · filed 2018-03-14 |
| 2015-09-30 | $0.00 10-K · filed 2017-03-15 | $85.86K derived: sum of 2 quarters · filed 2017-03-15 | $84.77K 10-Q · filed 2016-11-09 | $83.69K derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $85.86K 10-K · filed 2017-03-15 | $84.77K 10-Q · filed 2016-08-08 | $83.69K derived: sum of 3 quarters · filed 2017-03-15 | $82.20K derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | -$1.09K 10-K · filed 2017-03-15 | -$2.17K derived: sum of 2 quarters · filed 2017-03-15 | -$3.66K derived: sum of 3 quarters · filed 2017-03-15 | -$10.10K derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | -$1.08K 10-K · filed 2016-03-14 | -$2.57K derived: sum of 2 quarters · filed 2016-03-14 | -$9.01K derived: sum of 3 quarters · filed 2016-03-14 | -$18.42K 10-K · filed 2017-03-15 |
| 2014-09-30 | -$1.49K 10-K · filed 2016-03-14 | -$7.93K derived: sum of 2 quarters · filed 2016-03-14 | -$17.34K 10-Q · filed 2015-11-09 | -$30.81K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | -$6.44K 10-K · filed 2016-03-14 | -$15.85K 10-Q · filed 2015-08-10 | -$29.32K derived: sum of 3 quarters · filed 2016-03-14 | -$42.77K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | -$9.41K 10-K · filed 2016-03-14 | -$22.88K derived: sum of 2 quarters · filed 2016-03-14 | -$36.32K derived: sum of 3 quarters · filed 2016-03-14 | -$50.33K derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | -$13.47K 10-K · filed 2015-03-16 | -$26.92K derived: sum of 2 quarters · filed 2015-03-16 | -$40.92K derived: sum of 3 quarters · filed 2015-03-16 | -$55.08K 10-K · filed 2016-03-14 |
| 2013-09-30 | -$13.44K 10-K · filed 2015-03-16 | -$27.45K derived: sum of 2 quarters · filed 2015-03-16 | -$41.61K 10-Q · filed 2014-11-10 | -$54.16K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | -$14.01K 10-K · filed 2015-03-16 | -$28.17K 10-Q · filed 2014-08-11 | -$40.72K derived: sum of 3 quarters · filed 2015-03-16 | -$51.13K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | -$14.16K 10-K · filed 2015-03-16 | -$26.71K derived: sum of 2 quarters · filed 2015-03-16 | -$37.13K derived: sum of 3 quarters · filed 2015-03-16 | -$48.41K derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | -$12.55K 10-K · filed 2014-03-17 | -$22.97K derived: sum of 2 quarters · filed 2014-03-17 | -$34.26K derived: sum of 3 quarters · filed 2014-03-17 | -$44.02K 10-K · filed 2015-03-16 |
| 2012-09-30 | -$10.41K 10-K · filed 2014-03-17 | -$21.70K derived: sum of 2 quarters · filed 2014-03-17 | -$31.47K 10-Q · filed 2013-11-12 | -$43.42K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | -$11.29K 10-K · filed 2014-03-17 | -$21.06K 10-Q · filed 2013-08-09 | -$33.01K derived: sum of 3 quarters · filed 2014-03-17 | -$47.66K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | -$9.77K 10-K · filed 2014-03-17 | -$21.72K derived: sum of 2 quarters · filed 2014-03-17 | -$36.37K derived: sum of 3 quarters · filed 2014-03-17 | -$51.48K derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | -$11.95K 10-K · filed 2013-03-18 | -$26.60K derived: sum of 2 quarters · filed 2013-03-18 | -$41.71K derived: sum of 3 quarters · filed 2013-03-18 | -$51.15K 10-K · filed 2014-03-17 |
| 2011-09-30 | -$14.65K 10-K · filed 2013-03-18 | -$29.76K derived: sum of 2 quarters · filed 2013-03-18 | -$39.20K 10-Q · filed 2012-11-07 | -$55.11K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | -$15.11K 10-K · filed 2013-03-18 | -$24.55K 10-Q · filed 2012-08-09 | -$40.46K derived: sum of 3 quarters · filed 2013-03-18 | -$45.04K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | -$9.44K 10-K · filed 2013-03-18 | -$25.35K derived: sum of 2 quarters · filed 2013-03-18 | -$29.93K derived: sum of 3 quarters · filed 2013-03-18 | -$27.44K derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | -$15.90K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$20.49K derived: sum of 2 quarters · filed 2013-03-18 | -$18.00K derived: sum of 3 quarters · filed 2013-03-18 | -$24.95K 10-K · filed 2013-03-18 |
| 2010-09-30 | -$4.58K 10-Q · filed 2011-11-07 | -$2.10K derived: sum of 2 quarters · filed 2011-11-07 | -$9.04K 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $2.49K 10-Q · filed 2011-08-05 | -$4.46K 10-Q · filed 2011-08-05 | ||
| 2009-12-31 | -$47.44K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |